Real-time · AI · Cross-signal
Discover the power of real-time signals plus AI
Every contract, funding round, exec hire, and M&A move on ESYA Labs — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
ESYA Labs Partners with Alamar Biosciences to Revolutionize Biomarker Detection for Neurological Diseases
Dec 04, 2024•over 1 year ago
Contract Type
partnership
Description
ESYA Labs has announced a transformative partnership with Alamar Biosciences to revolutionise the detection and quantification of biomarkers for neurological and inflammatory diseases. By merging their respective strengths, the collaboration aims to create robust, targeted solutions to support the next generation of precision medicine.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months